Dr. Curtiland Deville
Claim this profileSibley Memorial Hospital
Studies Prostate Cancer
Studies Glioblastoma
6 reported clinical trials
10 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
Stage I
Stage II
2Glioblastoma
Affiliated Hospitals
Clinical Trials Curtiland Deville is currently running
Proton Therapy
for Sarcoma
This study is being done to examine whether proton therapy for certain kinds of sarcomas (extremity and trunk soft tissue) is safe and effective. As part of the study, patients will have five fractions of proton therapy before the participants have surgery for the sarcoma. The study will measure wound complications and functional outcomes / quality of life after the procedures. Patients will be asked to complete questionnaires about the treatment and quality of life from the time of enrollment until about two years after surgery. Otherwise, the participants will have standard of care follow ups with the treatment team.
Recruiting1 award N/A
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
More about Curtiland Deville
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Curtiland Deville has experience with
- Temozolomide
- ProstAtak® Immunotherapy
- Radium-223
- Stereotactic Ablative Radiotherapy (SABR)
- Low Dose Fractionated Radiation Therapy (LDFRT)
- Hypofractionated Proton Therapy
Breakdown of trials Curtiland Deville has run
Prostate Cancer
Glioblastoma
Protoplasmic Astrocytoma
Soft Tissue Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Curtiland Deville specialize in?
Curtiland Deville focuses on Prostate Cancer and Glioblastoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage I.
Is Curtiland Deville currently recruiting for clinical trials?
Yes, Curtiland Deville is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Curtiland Deville has studied deeply?
Yes, Curtiland Deville has studied treatments such as Temozolomide, ProstAtak® Immunotherapy, Radium-223.
What is the best way to schedule an appointment with Curtiland Deville?
Apply for one of the trials that Curtiland Deville is conducting.
What is the office address of Curtiland Deville?
The office of Curtiland Deville is located at: Sibley Memorial Hospital, Washington, District of Columbia 20016 United States. This is the address for their practice at the Sibley Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.